Effect of asymmetric dimethylarginine (ADMA) on heart failure development.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Nitric oxide

• Publication date

  2016-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.niox.2016.02.006PMID 26923818PMCID PMC5017793
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• S-nitrosylation of PDE5 increases its ubiquitin-proteasomal degradation.

  2015cited by this paper
• Phosphodiesterase 9A Controls Nitric-oxide Independent cGMP and Hypertrophic Heart Disease

  2015cited by this paper
• Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction

  2015cited by this paper
• Soluble Guanylate Cyclase: A New Therapeutic Target for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

  2015cited by this paper
• Endothelial Dimethylarginine Dimethylaminohydrolase 1 Is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic Homeostasis

  2015cited by this paper
• Proteasomal and lysosomal protein degradation and heart disease.

  2014cited by this paper
• Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.

  2014cited by this paper
• Endoplasmic Reticulum Stress Sensor Protein Kinase R–Like Endoplasmic Reticulum Kinase (PERK) Protects Against Pressure Overload–Induced Heart Failure and Lung Remodeling

  2014cited by this paper
• Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valve

  2014cited by this paper
• Convergence of G Protein–Coupled Receptor and S-Nitrosylation Signaling Determines the Outcome to Cardiac Ischemic Injury

  2013cited by this paper
• DDAH1 Deficiency Attenuates Endothelial Cell Cycle Progression and Angiogenesis

  2013cited by this paper
• Plasma Asymmetric Dimethylarginine and Adverse Events in Patients with Atrial Fibrillation Referred for Coronary Angiogram

  2013cited by this paper
• Nitric Oxide Synthases in Heart Failure

  2013cited by this paper
• Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties.

  2013cited by this paper
• Soluble guanylate cyclase: a potential therapeutic target for heart failure

  2013cited by this paper
• Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure

  2012cited by this paper
• Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.

  2012cited by this paper
• Asymmetrical Dimethylarginine - More Sensitive than NT-proBNP to Diagnose Heart Failure in Adults with Congenital Heart Disease

  2012cited by this paper
• The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.

  2012cited by this paper
• Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure.

  2012cited by this paper
• Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

  2012cited by this paper
• Dimethylarginine Dimethylaminohydrolase 1 Modulates Endothelial Cell Growth Through Nitric Oxide and Akt

  2011cited by this paper
• Production of free methylarginines via the proteasome and autophagy pathways in cultured cells.

  2011cited by this paper
• Management of Chronic Heart Failure in Adults: Synopsis of the National Institute for Health and Clinical Excellence Guideline

  2011cited by this paper
• Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association

  2011cited by this paper
• Oxidation of myofibrillar proteins in human heart failure.

  2011cited by this paper
• Dimethylarginine Dimethylaminohydrolase-1 Is the Critical Enzyme for Degrading the Cardiovascular Risk Factor Asymmetrical Dimethylarginine

  2011cited by this paper
• Impaired S-Nitrosylation of the Ryanodine Receptor Caused by Xanthine Oxidase Activity Contributes to Calcium Leak in Heart Failure*

  2010cited by this paper
• Bile Acids as Regulators of Hepatic Lipid and Glucose Metabolism

  2010cited by this paper
• Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine.

  2010cited by this paper
• Review article: Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus

  2010cited by this paper
• Oxidative Stress Regulates Left Ventricular PDE5 Expression in the Failing Heart

  2010cited by this paper
• Vascular Endothelial-Specific Dimethylarginine Dimethylaminohydrolase-1–Deficient Mice Reveal That Vascular Endothelium Plays an Important Role in Removing Asymmetric Dimethylarginine

  2009cited by this paper
• Bile acids as regulatory molecules

  2009cited by this paper
• Detrimental effect of combined exercise training and eNOS overexpression on cardiac function after myocardial infarction.

  2009cited by this paper
• Neuronal Nitric Oxide Synthase Protects Against Myocardial Infarction–Induced Ventricular Arrhythmia and Mortality in Mice

  2009cited by this paper
• Coordinated Regulation of Dimethylarginine Dimethylaminohydrolase-1 and Cationic Amino Acid Transporter-1 by Farnesoid X Receptor in Mouse Liver and Kidney and Its Implication in the Control of Blood Levels of Asymmetric Dimethylarginine

  2009cited by this paper
• Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community

  2009cited by this paper
• Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production.

  2009cited by this paper
• Asymmetrical dimethylarginine level in atrial fibrillation

  2008cited by this paper
• Dimethylarginine Dimethylaminohydrolase Overexpression Enhances Insulin Sensitivity

  2008cited by this paper
• Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure.

  2008cited by this paper
• Impairment of endothelial nitric oxide synthase causes abnormal fat and glycogen deposition in liver.

  2008cited by this paper
• Disruption of methylarginine metabolism impairs vascular homeostasis

  2007cited by this paper
• Ursodeoxycholic acid: Mechanism of action and novel clinical applications

  2007cited by this paper
• Evidence for the Pathophysiological Role of Endogenous Methylarginines in Regulation of Endothelial NO Production and Vascular Function*

  2007cited by this paper
• Metabolic Profiling of Arginine and Nitric Oxide Pathways Predicts Hemodynamic Abnormalities and Mortality in Patients With Cardiogenic Shock After Acute Myocardial Infarction

  2007cited by this paper
• Inducible Nitric Oxide Synthase Deficiency Protects the Heart From Systolic Overload–Induced Ventricular Hypertrophy and Congestive Heart Failure

  2007cited by this paper
• Asymmetric Dimethylarginine Enhances Cardiovascular Risk Prediction in Patients With Chronic Heart Failure

  2007cited by this paper
• Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells.

  2007cited by this paper
• Asymmetrical Dimethylarginine in Renal Disease: Limits of Variation or Variation Limits?

  2007cited by this paper
• Asymmetrical Dimethylarginine Inhibits Shear Stress–Induced Nitric Oxide Release and Dilation and Elicits Superoxide-Mediated Increase in Arteriolar Tone

  2007cited by this paper
• Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload.

  2007cited by this paper
• Farnesoid X receptor is essential for normal glucose homeostasis.

  2006cited by this paper
• Functional Relevance of Golgi- and Plasma Membrane–Localized Endothelial NO Synthase in Reconstituted Endothelial Cells

  2006cited by this paper
• Farnesoid X Receptor Agonist Reduces Serum Asymmetric Dimethylarginine Levels through Hepatic Dimethylarginine Dimethylaminohydrolase-1 Gene Regulation*

  2006cited by this paper
• Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes

  2006cited by this paper
• Neuronal nitric oxide synthase controls enzyme activity pattern of mitochondria and lipid metabolism

  2006cited by this paper
• Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking

  2006cited by this paper
• Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.

  2005cited by this paper
• Overexpression of Dimethylarginine Dimethylaminohydrolase Reduces Tissue Asymmetric Dimethylarginine Levels and Enhances Angiogenesis

  2005cited by this paper
• Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

  2005cited by this paper
• Asymmetric Dimethylarginine and the Risk of Cardiovascular Events and Death in Patients With Coronary Artery Disease: Results from the AtheroGene Study

  2005cited by this paper
• Dimethylarginine Dimethylaminohydrolase Overexpression Suppresses Graft Coronary Artery Disease

  2005cited by this paper
• Intracellular location regulates calcium-calmodulin-dependent activation of organelle-restricted eNOS.

  2005cited by this paper
• Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts.

  2005cited by this paper
• The role of inflammation in atherothrombosis: implications for clinical practice

  2005cited by this paper
• DDAH gene and cardiovascular risk

  2005cited by this paper
• Hydrophilic bile salt ursodeoxycholic acid protects myocardium against reperfusion injury in a PI3K/Akt dependent pathway.

  2005cited by this paper
• Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.

  2005cited by this paper
• Endogenous Methylarginines Modulate Superoxide as Well as Nitric Oxide Generation from Neuronal Nitric-oxide Synthase

  2005cited by this paper
• DDAH gene and cardiovascular risk

  2005cited by this paper
• Premature death and age-related cardiac dysfunction in male eNOS-knockout mice.

  2004cited by this paper
• Cardiomyocyte-Specific Overexpression of Nitric Oxide Synthase 3 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction

  2004cited by this paper
• Asymmetric Dimethylarginine Produces Vascular Lesions in Endothelial Nitric Oxide Synthase–Deficient Mice: Involvement of Renin-Angiotensin System and Oxidative Stress

  2004cited by this paper
• Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor.

  2004cited by this paper
• Care of patients with end-stage heart disease

  2004cited by this paper
• Cytomegalovirus Infection Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine in Transplant Arteriosclerosis

  2004cited by this paper
• Primary biliary cirrhosis.

  2003cited by this paper
• Alterations of gene expression in failing myocardium following left ventricular assist device support.

  2003cited by this paper
• Dimethylarginine Dimethylaminohydrolase Regulates Nitric Oxide Synthesis: Genetic and Physiological Evidence

  2003cited by this paper
• Effect of PDE5 inhibition on coronary hemodynamics in pacing-induced heart failure.

  2003cited by this paper
• Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase

  2003cited by this paper
• Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice

  2003cited by this paper
• Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension.

  2003cited by this paper
• Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice.

  2003cited by this paper
• Metabolism of Asymmetric Dimethylarginines Is Regulated in the Lung Developmentally and With Pulmonary Hypertension Induced by Hypobaric Hypoxia

  2003cited by this paper
• Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite.

  2002cited by this paper
• Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus: Role of Asymmetric Dimethylarginine and Dimethylarginine Dimethylaminohydrolase

  2002cited by this paper
• Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms

  2002cited by this paper
• Nitric Oxide Modulates Myocardial Oxygen Consumption in the Failing Heart

  2002cited by this paper
• Nitric oxide as a unique signaling molecule in the vascular system: a historical overview.

  2002cited by this paper
• Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview.

  2002cited by this paper
• Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms.

  2002cited by this paper
• Endothelial Nitric Oxide Synthase Limits Left Ventricular Remodeling After Myocardial Infarction in Mice

  2001cited by this paper
• World Wide Web at:

  2001cited by this paper
• State of the arg: protein methylation at arginine comes of age.

  2001cited by this paper
• An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes.

  2000cited by this paper
• Identification of a chemical tool for the orphan nuclear receptor FXR.

  2000cited by this paper
• Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins.

  2000cited by this paper

• L-Arginine and Nitric Oxide in Vascular Regulation—Experimental Findings in the Context of Blood Donation

  2025cites this paper
• The Link Between Venous and Arterial Thrombosis: Is There a Role for Endothelial Dysfunction?

  2025cites this paper
• Heart saver: Comprehensive investigation of (redox-) proteomic and thiol metabolite changes induced by Cana-, Dapa-, Empagliflozin treatment in 2D and 3D heart cell models reveals increased mitochondrial activity and glutathione redox defense and involvement of redox signaling.

  2025cites this paper
• Asymmetric dimethylarginine mediates oxidative stress and atrial remodeling in HL-1 cells

  2025cites this paper
• Comparative transcriptome and methylome of polar bears, giant and red pandas reveal diet‐driven adaptive evolution

  2024cites this paper
• Endothelial dysfunction in patients with systemic AL amyloidosis

  2024cites this paper
• E-Selectin and Asymmetric Dimethylarginine Levels in Adult Cyanotic Congenital Heart Disease: Their Relation to Biochemical Parameters, Vascular Function, and Clinical Status

  2024cites this paper
• A Set of Possible Markers for Monitoring Heart Failure and Cognitive Impairment Associated: A Review of Literature from the Past 5 Years

  2024cites this paper
• Pharmacokinetic effect of Astragalus membranaceus and Panax notoginseng saponins on arginine absorption and nitric oxide production in healthy subjects

  2023cites this paper
• Dysfunctional and Dysregulated Nitric Oxide Synthases in Cardiovascular Disease: Mechanisms and Therapeutic Potential

  2023cites this paper
• Modulation of the nitric oxide/cGMP pathway in cardiac contraction and relaxation: potential role in heart failure treatment.

  2023cites this paper
• Vitamin D Deficiency-Associated Comorbidities: A Protein Network Dynamics Perspective

  2023cites this paper
• The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets.

  2023cites this paper
• Study of Homocysteine, SDMA, ADMA, UMOD, AVP, and KIM-1 in serum of chronic renal disease patients suffering from Type-2 diabetes in Basra Province

  2023cites this paper
• Evaluation of Asymmetric Dimethylarginine Serum Level and Left Ventricular Function by 2D Speckle Tracking Echocardiography in Children on Regular Hemodialysis.

  2022cites this paper
• The ADMA-DDAH1 axis in ovarian apoptosis of polycystic ovary syndrome.

  2022cites this paper
• A new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approach

  2022cites this paper
• Cognitive decline in heart failure: Biomolecular mechanisms and benefits of exercise.

  2022cites this paper
• Effects of Physical Prehabilitation on the Dynamics of the Markers of Endothelial Function in Patients Undergoing Elective Coronary Bypass Surgery

  2022cites this paper
• Protective Effects of L-Arginine on Mitochondria of Rat Epididymis in Hyperhomocysteinemia Induced by Prolonged Methionine Load

  2022cites this paper
• Effect of l-arginine on cardiac reverse remodeling and quality of life in patients with heart failure.

  2021cites this paper
• DDAH1 SNP rs480414 that protects against the development of pulmonary hypertension in bronchopulmonary dysplasia results in lower nitric oxide production in neonatal cord blood-derived lymphoblastoid cell lines

  2021cites this paper
• Circulating Hydrogen Sulfide (H2S) and Nitric Oxide (NO) Levels Are Significantly Reduced in HIV Patients Concomitant with Increased Oxidative Stress Biomarkers

  2021cites this paper
• Effects of Piper sarmentosum on Metabolic Syndrome and Its Related Complications: A Review of Preclinical Evidence

  2021cites this paper
• Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology.

  2020cites this paper
• A drug cocktail for protecting against ischemia-reperfusion injury.

  2020cites this paper
• Mixture of MMP-2, MLC, and NOS Inhibitors Affects NO Metabolism and Protects Heart from Cardiac I/R Injury

  2020cites this paper
• Crucial markers showing the risk of coronary artery disease in obesity: ADMA and neopterin

  2020cites this paper
• Klotho gene improves oxidative stress injury after myocardial infarction

  2020cites this paper
• The Importance of a New Cardiovascular Risk Factor - Asymmetric Dimethylarginine.

  2020cites this paper
• Pantoprazole Rescue The Vascular Endothelial Dysfunction In Diabetic Rats Through DDAH/ADMA/Enos/NO Pathway

  2020cites this paper
• Novel technique for the simultaneous isolation of cardiac fibroblasts and epicardial stromal cells from the infarcted murine heart.

  2019cites this paper
• Profound Increase of Lung Airway Resistance in Heart Failure: a Potential Important Contributor for Dyspnea

  2019cites this paper
• Uremic Toxin-Targeting as a Therapeutic Strategy for Preventing Cardiorenal Syndrome.

  2019cites this paper
• Dimethylarginine dimethylaminohydrolase 1 deficiency aggravates monocrotaline-induced pulmonary oxidative stress, pulmonary arterial hypertension and right heart failure in rats.

  2019cites this paper
• Clinical Autonomic and Mitochondrial Disorders: Diagnosis, Prevention, and Treatment for Mind-Body Wellness

  2019cites this paper
• Association of Asymmetric Dimethylarginine and Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy

  2019cites this paper
• Isolevuglandin scavenger attenuates pressure overload-induced cardiac oxidative stress, cardiac hypertrophy, heart failure and lung remodeling.

  2019cites this paper
• Elevated circulating asymmetric dimethylarginine levels in rheumatoid arthritis: a systematic review and meta-analysis

  2019cites this paper
• Protective effect of epigallocatechin gallate on endothelial disorders in atherosclerosis.

  2019cites this paper
• Piper sarmentosum Promotes Endothelial Nitric Oxide Production by Reducing Asymmetric Dimethylarginine in Tumor Necrosis Factor-α-Induced Human Umbilical Vein Endothelial Cells

  2019cites this paper
• Mind-Body Wellness Program Benefits

  2019cites this paper
• Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease.

  2018influential citation
• Asymmetrical Dimethylarginine Levels in Hepatitis B Virus-Positive Patients

  2018cites this paper
• Serum concentrations of asymmetric and symmetric dimethylarginine are associated with mortality in acute heart failure patients

  2018cites this paper
• Association between asymmetric dimethylarginine serum levels and left ventricular longitudinal deformation in patients with normal ejection fractions: a two-dimensional speckle-tracking echocardiography examination

  2018cites this paper
• Relationship of ADMA Levels with Cardiovascular Parameters in Patients with Peritoneal Dialysis: A Bioimpedance Analysis Study

  2018cites this paper
• Oxidative stress in pregnant women with diabetes mellitus

  2018cites this paper
• Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction

  2017cites this paper
• The asymmetric dimethylarginine-mediated inhibition of nitric oxide in the rostral ventrolateral medulla contributes to regulation of blood pressure in hypertensive rats.

  2017cites this paper
• La régulation de la perfusion musculaire dépendante du monoxyde d’azote (NO) : effet de l’aptitude aérobie et des facteurs de risques cardiovasculaires liés à la diméthylarginine asymétrique

  2017cites this paper
• Asymmetric dimethylarginine and M 30 concentrations in heart failure

  2017cites this paper
• Chapter 19 – Asymmetric-Dimethylarginine

  2017cites this paper
• Ammonia Reduces Intracellular Asymmetric Dimethylarginine in Cultured Astrocytes Stimulating Its y+LAT2 Carrier-Mediated Loss

  2017cites this paper
• Regulation of c-Jun N-Terminal Protein Kinase (JNK) Pathway in Apoptosis of Endothelial Outgrowth Cells Induced by Asymmetric Dimethylarginine

  2017cites this paper
• Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.

  2017cites this paper
• Associations of Exhaled Carbon Monoxide and Fractional Exhaled Nitric Oxide with Metabolic Syndrome: A Cohort Study

  2016cites this paper